NCT07109726 A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations Status RECRUITING Phase PHASE1/PHASE2
NCT07108140 Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors Status TERMINATED Phase EARLY_PHASE1
NCT07107633 A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor. Status RECRUITING Phase PHASE2
NCT07100925 A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07094204 A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors Status RECRUITING Phase PHASE1
NCT07086768 Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07071909 Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells Status WITHDRAWN Phase PHASE1/PHASE2
NCT07069062 A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07056556 A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT07030439 A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State Status COMPLETED Phase PHASE1
NCT07019194 An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition Status COMPLETED Phase PHASE1
NCT07003321 A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06980519 MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer Status AVAILABLE Phase N/A
NCT06980506 MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer Status AVAILABLE Phase N/A
NCT06975293 STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas Status RECRUITING Phase PHASE1/PHASE2
NCT06971523 A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies Status RECRUITING Phase PHASE1/PHASE2
NCT06966583 NAD+ Supplement(NMN)With Radioimmunotherapy in Advanced NSCLC Status NOT_YET_RECRUITING Phase PHASE1